These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22197995)

  • 21. Higher expression of WNT5A protein in oral squamous cell carcinoma compared with dysplasia and oral mucosa with a normal appearance.
    Prgomet Z; Andersson T; Lindberg P
    Eur J Oral Sci; 2017 Aug; 125(4):237-246. PubMed ID: 28603941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of E-cadherin/catenin complex in laryngeal cancer.
    Mittari E; Charalabopoulos A; Batistatou A; Charalabopoulos K
    Exp Oncol; 2005 Dec; 27(4):257-61. PubMed ID: 16404343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-Arrestin-1 expression and epithelial-to-mesenchymal transition in laryngeal carcinoma.
    Marioni G; Nicolè L; Cappellesso R; Marchese-Ragona R; Fasanaro E; Di Carlo R; La Torre FB; Nardello E; Sanavia T; Ottaviano G; Fassina A
    Int J Biol Markers; 2019 Mar; 34(1):33-40. PubMed ID: 30854928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen receptor-beta expression in human laryngeal carcinoma: correlation with the expression of epithelial-mesenchymal transition specific biomarkers.
    Goulioumis AK; Fuxe J; Varakis J; Repanti M; Goumas P; Papadaki H
    Oncol Rep; 2009 Nov; 22(5):1063-8. PubMed ID: 19787222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization and level of expression of beta-catenin in human laryngeal squamous cell carcinoma.
    Lopez-Gonzalez JS; Cristerna-Sanchez L; Vazquez-Manriquez ME; Jimenez-Orci G; Aguilar-Cazares D
    Otolaryngol Head Neck Surg; 2004 Jan; 130(1):89-93. PubMed ID: 14726916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
    Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
    Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of E-cadherin, Beta-catenin, N-cadherin, ZEB1 and αSMA as Epithelial Mesenchymal Transition markers with prognostic factors in early and advanced stage laryngeal squamous cell carcinomas.
    Kucuk U; Ekmekci S; Talu CK; Pekcevik Y; Cukurova I
    Indian J Pathol Microbiol; 2023; 66(2):237-245. PubMed ID: 37077062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
    Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
    Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulated Chibby in laryngeal squamous cell carcinoma with increased expression in laryngeal carcinoma Hep-2 cells.
    Xu J; Ren G; Zhao DA; Li BA; Cai CF; Zhou Y; Luo XY
    Oncol Rep; 2014 Nov; 32(5):1947-56. PubMed ID: 25175341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential changes in cadherin-catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma.
    Sanders DS; Bruton R; Darnton SJ; Casson AG; Hanson I; Williams HK; Jankowski J
    Int J Cancer; 1998 Dec; 79(6):573-9. PubMed ID: 9842964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
    Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An essential role for N-cadherin and beta-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells.
    Li S; Jiao J; Lu Z; Zhang M
    Oncol Rep; 2009 May; 21(5):1223-33. PubMed ID: 19360298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer.
    Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Yang LH; Liu Y; Wang EH
    Pathol Oncol Res; 2013 Apr; 19(2):281-6. PubMed ID: 23086683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation.
    Chaw SY; Abdul Majeed A; Dalley AJ; Chan A; Stein S; Farah CS
    Oral Oncol; 2012 Oct; 48(10):997-1006. PubMed ID: 22704062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical assessment of E-cadherin and β-catenin in the histological differentiations of oral squamous cell carcinoma.
    Zaid KW
    Asian Pac J Cancer Prev; 2014; 15(20):8847-53. PubMed ID: 25374218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma.
    Lin YC; Wu MY; Li DR; Wu XY; Zheng RM
    World J Gastroenterol; 2004 Nov; 10(22):3235-9. PubMed ID: 15484291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of beta-catenin protein in laryngeal squamous-cell carcinoma].
    Pietruszewska W; Kobos J; Gryczyński M
    Otolaryngol Pol; 2004; 58(5):949-56. PubMed ID: 15732781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of E-cadherin and β-catenin expression in HPV-negative oropharyngeal squamous cell carcinomas.
    García-Pedrero JM; García-Cabo P; Ángeles Villaronga M; Hermida-Prado F; Granda-Díaz R; Allonca E; Rodrigo JP
    Head Neck; 2017 Nov; 39(11):2293-2300. PubMed ID: 28815780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dickkopf-1 is a novel prognostic biomarker for laryngeal squamous cell carcinoma.
    Shi Y; Gong HL; Zhou L; Tian J; Wang Y
    Acta Otolaryngol; 2014 Jul; 134(7):753-9. PubMed ID: 24834937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables.
    Rosado P; Lequerica-Fernández P; Fernández S; Allonca E; Villallaín L; de Vicente JC
    Br J Oral Maxillofac Surg; 2013 Mar; 51(2):149-56. PubMed ID: 22525043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.